Injectable hydroxocobalamin is the standard UK treatment for confirmed B12 deficiency, particularly when neurological symptoms are present or absorption is impaired, providing rapid correction with doses given initially three times weekly then every two to three months
Please notify us of any prescription or over-the-counter drugs you may be taking upon scheduling or before your visit
if neurological involvement is present, maintenance is every two months Oral therapy is generally not appropriate where absorption is impaired (e.g., pernicious anaemia), as adequate levels cannot be reliably achieved Because B12 is water-soluble and any excess beyond hepatic storage capacity is excreted in the urine, it has a low toxicity profile
Systemic Reactions Including Fever Systemic reactions to high-dose vitamin B12 can include fever, fatigue, and feeling unwell
Description SLU-PP-332 Peptide SLU-PP-332 is a synthetic compound investigated for its activity as a REV-ERB/ agonist , Chemical Makeup Molecular Formula: C30H35N5O3 Molecular Weight: 513.63 g/mol Mechanism of Action: REV-ERB/ receptor agonist Solubility: DMSO, ethanol Structure Type: Non-peptidic small molecule Research Use Only SLU-PP-332 is provided for in vitro and in vivo laboratory research use only